Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
This molecule is a **long non-coding RNA** transcript ("novel transcript, antisense to ANKRD54 and EIF3D") identified in genome annotation databases by the Ensembl identifier **ENSG00000302270**[1][3]. It is transcribed from the antisense strand overlapping or adjacent to the protein-coding genes **ANKRD54** (ankyrin repeat domain 54) and **EIF3D** (eukaryotic translation initiation factor 3 subunit D). Its sequence, expression pattern, and possible biological function have not been experimentally characterized or validated. There is no published evidence it plays a role as a receptor, enzyme, transporter, drug target, or biomarker, nor is it associated with any recognized disease.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Novel transcript, antisense to ANKRD54 and EIF3D.